BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

426 related articles for article (PubMed ID: 24189068)

  • 1. Protein arginine methyltransferase 5 (PRMT5) inhibition induces lymphoma cell death through reactivation of the retinoblastoma tumor suppressor pathway and polycomb repressor complex 2 (PRC2) silencing.
    Chung J; Karkhanis V; Tae S; Yan F; Smith P; Ayers LW; Agostinelli C; Pileri S; Denis GV; Baiocchi RA; Sif S
    J Biol Chem; 2013 Dec; 288(49):35534-47. PubMed ID: 24189068
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bromodomain protein 7 interacts with PRMT5 and PRC2, and is involved in transcriptional repression of their target genes.
    Tae S; Karkhanis V; Velasco K; Yaneva M; Erdjument-Bromage H; Tempst P; Sif S
    Nucleic Acids Res; 2011 Jul; 39(13):5424-38. PubMed ID: 21447565
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protein arginine methyltransferase 5 suppresses the transcription of the RB family of tumor suppressors in leukemia and lymphoma cells.
    Wang L; Pal S; Sif S
    Mol Cell Biol; 2008 Oct; 28(20):6262-77. PubMed ID: 18694959
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protein arginine methyltransferase 5 (PRMT5) promotes survival of lymphoma cells via activation of WNT/β-catenin and AKT/GSK3β proliferative signaling.
    Chung J; Karkhanis V; Baiocchi RA; Sif S
    J Biol Chem; 2019 May; 294(19):7692-7710. PubMed ID: 30885941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein arginine methyltransferase 5 represses tumor suppressor miRNAs that down-regulate CYCLIN D1 and c-MYC expression in aggressive B-cell lymphoma.
    Karkhanis V; Alinari L; Ozer HG; Chung J; Zhang X; Sif S; Baiocchi RA
    J Biol Chem; 2020 Jan; 295(5):1165-1180. PubMed ID: 31822509
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nuclear cyclin D1/CDK4 kinase regulates CUL4 expression and triggers neoplastic growth via activation of the PRMT5 methyltransferase.
    Aggarwal P; Vaites LP; Kim JK; Mellert H; Gurung B; Nakagawa H; Herlyn M; Hua X; Rustgi AK; McMahon SB; Diehl JA
    Cancer Cell; 2010 Oct; 18(4):329-40. PubMed ID: 20951943
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PRMT5 is required for lymphomagenesis triggered by multiple oncogenic drivers.
    Li Y; Chitnis N; Nakagawa H; Kita Y; Natsugoe S; Yang Y; Li Z; Wasik M; Klein-Szanto AJ; Rustgi AK; Diehl JA
    Cancer Discov; 2015 Mar; 5(3):288-303. PubMed ID: 25582697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The PRC2 complex directly regulates the cell cycle and controls proliferation in skeletal muscle.
    Adhikari A; Davie JK
    Cell Cycle; 2020 Sep; 19(18):2373-2394. PubMed ID: 32816597
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validation of protein arginine methyltransferase 5 (PRMT5) as a candidate therapeutic target in the spontaneous canine model of non-Hodgkin lymphoma.
    Sloan SL; Renaldo KA; Long M; Chung JH; Courtney LE; Shilo K; Youssef Y; Schlotter S; Brown F; Klamer BG; Zhang X; Yilmaz AS; Ozer HG; Valli VE; Vaddi K; Scherle P; Alinari L; Kisseberth WC; Baiocchi RA
    PLoS One; 2021; 16(5):e0250839. PubMed ID: 33989303
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective inhibition of protein arginine methyltransferase 5 blocks initiation and maintenance of B-cell transformation.
    Alinari L; Mahasenan KV; Yan F; Karkhanis V; Chung JH; Smith EM; Quinion C; Smith PL; Kim L; Patton JT; Lapalombella R; Yu B; Wu Y; Roy S; De Leo A; Pileri S; Agostinelli C; Ayers L; Bradner JE; Chen-Kiang S; Elemento O; Motiwala T; Majumder S; Byrd JC; Jacob S; Sif S; Li C; Baiocchi RA
    Blood; 2015 Apr; 125(16):2530-43. PubMed ID: 25742700
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of a PRMT5-dependent repressor complex linked to silencing of human fetal globin gene expression.
    Rank G; Cerruti L; Simpson RJ; Moritz RL; Jane SM; Zhao Q
    Blood; 2010 Sep; 116(9):1585-92. PubMed ID: 20495075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PRMT5 functionally associates with EZH2 to promote colorectal cancer progression through epigenetically repressing CDKN2B expression.
    Yang L; Ma DW; Cao YP; Li DZ; Zhou X; Feng JF; Bao J
    Theranostics; 2021; 11(8):3742-3759. PubMed ID: 33664859
    [No Abstract]   [Full Text] [Related]  

  • 13. JARID2 and the PRC2 complex regulate the cell cycle in skeletal muscle.
    Adhikari A; Mainali P; Davie JK
    J Biol Chem; 2019 Dec; 294(51):19451-19464. PubMed ID: 31578284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PRMT5-mediated histone arginine methylation antagonizes transcriptional repression by polycomb complex PRC2.
    Liu F; Xu Y; Lu X; Hamard PJ; Karl DL; Man N; Mookhtiar AK; Martinez C; Lossos IS; Sun J; Nimer SD
    Nucleic Acids Res; 2020 Apr; 48(6):2956-2968. PubMed ID: 32025719
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protein arginine methyltransferase 5 (PRMT5) activates WNT/β-catenin signalling in breast cancer cells via epigenetic silencing of DKK1 and DKK3.
    Shailesh H; Siveen KS; Sif S
    J Cell Mol Med; 2021 Feb; 25(3):1583-1600. PubMed ID: 33462997
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclin D1 inhibits peroxisome proliferator-activated receptor gamma-mediated adipogenesis through histone deacetylase recruitment.
    Fu M; Rao M; Bouras T; Wang C; Wu K; Zhang X; Li Z; Yao TP; Pestell RG
    J Biol Chem; 2005 Apr; 280(17):16934-41. PubMed ID: 15713663
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The dual epigenetic role of PRMT5 in acute myeloid leukemia: gene activation and repression via histone arginine methylation.
    Tarighat SS; Santhanam R; Frankhouser D; Radomska HS; Lai H; Anghelina M; Wang H; Huang X; Alinari L; Walker A; Caligiuri MA; Croce CM; Li L; Garzon R; Li C; Baiocchi RA; Marcucci G
    Leukemia; 2016 Apr; 30(4):789-99. PubMed ID: 26536822
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Androgens suppress EZH2 expression via retinoblastoma (RB) and p130-dependent pathways: a potential mechanism of androgen-refractory progression of prostate cancer.
    Bohrer LR; Chen S; Hallstrom TC; Huang H
    Endocrinology; 2010 Nov; 151(11):5136-45. PubMed ID: 20881251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protein arginine methyltransferase 5-mediated epigenetic silencing of IRX1 contributes to tumorigenicity and metastasis of gastric cancer.
    Liu X; Zhang J; Liu L; Jiang Y; Ji J; Yan R; Zhu Z; Yu Y
    Biochim Biophys Acta Mol Basis Dis; 2018 Sep; 1864(9 Pt B):2835-2844. PubMed ID: 29802960
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The tumor suppressor Rb and its related Rbl2 genes are regulated by Utx histone demethylase.
    Terashima M; Ishimura A; Yoshida M; Suzuki Y; Sugano S; Suzuki T
    Biochem Biophys Res Commun; 2010 Aug; 399(2):238-44. PubMed ID: 20650264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.